Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
BioStem Technologies, Inc. - SIC # 2834 - PHARMACEUTICAL PREPARATIONS
Ticker
Exchange
SIC #
Website
Latest Ticker
BSEM
Nasdaq
2834
biostemtechnologies.com
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for BioStem Technologies, Inc.
BioStem (BSEM) Q3 2026 Earnings Call Transcript
- Nov 12th, 2026 10:43 pm
BioStem Technologies, Inc. (BSEM) Reports Q3 Loss, Beats Revenue Estimates
- Nov 12th, 2026 3:05 pm
BioStem Technologies Reports Third Quarter 2026 Financial Results; Grows Hospital Revenue for Second Consecutive Quarter as Customers Expand Use of Portfolio
- Nov 12th, 2026 2:05 pm
Certara, Inc. (CERT) Tops Q3 Earnings and Revenue Estimates
- Nov 5th, 2026 6:35 am
BioStem Technologies to Host Third Quarter 2026 Financial Results Conference Call on November 12, 2026
- Oct 29th, 2026 2:05 pm
BioStem Technologies’ CEO and COO Invest $1 Million in Cash Through Exercise of Stock Options
- Oct 8th, 2026 5:00 am
BioStem Technologies Strengthens Placental Allograft and Umbilical Tissue Patent Portfolio
- Oct 1st, 2026 5:00 am
BioStem Technologies Announces $3 Million Private Placement Priced At-The-Market Under Nasdaq Rules
- Sep 30th, 2026 6:00 am
Terminal1, the operating system built for public companies, announced today that BioStem Technologies, Inc. (NASDAQ: BSEM) has joined the Terminal1 platform
- Sep 21st, 2026 2:30 pm
BioStem Technologies Secures Up to $40 Million in a Committed Equity Facility
- Sep 18th, 2026 5:00 am
BioStem Technologies Opens Hospital Access for VENDAJE® and VENDAJE AC® Through Vizient and Premier
- Sep 4th, 2026 5:00 am
BioStem Technologies Eyes Surgical Growth, Manufacturing Shift After BioTissue Deal
- Aug 21st, 2026 7:01 pm
Sidoti Events, LLC's August Micro-Cap Virtual Conference
- Aug 18th, 2026 8:00 am
BioStem Technologies to Present at the Sidoti MicroCap Conference
- Aug 14th, 2026 2:05 pm
BioStem Technologies Inc (BSEM) (Q2 2026) Earnings Call Highlights: Revenue Surges to $7. ...
- Aug 12th, 2026 11:03 pm
BioStem Technologies Q2 Earnings Call Highlights
- Aug 12th, 2026 10:04 pm
BioStem Technologies, Inc. (BSEM) Reports Q2 Loss, Beats Revenue Estimates
- Aug 12th, 2026 3:40 pm
BioStem Technologies Reports Second Quarter 2026 Financial Results
- Aug 12th, 2026 2:05 pm
Codexis (CDXS) Reports Q2 Loss, Tops Revenue Estimates
- Aug 11th, 2026 3:45 pm
Scroll